BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15161697)

  • 1. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y; Kesavan P; Nakada MT; Yan L
    Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
    Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
    Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
    Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
    Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma.
    Rosenthal EL; Shreenivas S; Peters GE; Grizzle WE; Desmond R; Gladson CL
    Laryngoscope; 2003 Aug; 113(8):1406-10. PubMed ID: 12897567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
    Rosenthal EL; Vidrine DM; Zhang W
    Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
    Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
    J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.
    Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L
    Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
    Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
    Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
    Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
    Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.
    Gabison EE; Hoang-Xuan T; Mauviel A; Menashi S
    Biochimie; 2005; 87(3-4):361-8. PubMed ID: 15781323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.